Share Cafe Webinar - Potency assay data was in place for GvHD trial, page-15

So after watching this for a few years I have finally bought in. I'm no expert when it comes to biotech but last year I felt the risk of FDA rejection was too
high for me.

I made money once from a US biotech called Sarepta and learned then how long and tortuous the pathway to approval and then commercialisation can be. I have a feeling that MSB is now on a track that justifies the still high risk of investing. It is a binary play: it will either be zero or $10+, depending on your timeline (see next point).

My timeline for approval and commercialisation is 12 - 36 months. 12 being the best case, longer than 36 and I'll sell out and take the loss.

I note that this forum has some deep experts, far more knowledgeable than me, on the dark ways of the FDA approvals process. Anyone want to challenge my timeline?